Osteonecrosis of the jaw secondary to oral alendronate. Report of three cases;Osteonecrosis maxilar secundaria al uso de bisfosfonatos por vía oral. Exposición de tres casos clínicos relacionados con alendronato

Revista Medica de Chile

Volumn 137, Issue 2, 2009, Pages 275-279

  Bocanegra Pérez, Sacramento ^b   Vicente Barrero, Mario ^a   Sosa Henríquez, Manuel ^a   Blancoa, Arwen Gebaguer ^b   Knezevic, Milan ^a   Castellano Navarro, José María ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^b NONE

Author keywords

Alendronates; Biphosphonates; Osteonecrosis

Indexed keywords

ALENDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; JAW DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS;

AGED; AGED, 80 AND OVER; ALENDRONATE; BONE DENSITY CONSERVATION AGENTS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; JAW DISEASES; MAXILLARY DISEASES; OSTEONECROSIS;

EID: 67650159594     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Woo SB, Hellstein JW, Kalmar JR. Systematic review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753-61.
2. Delmas PD, Meunier PJ. The management of Paget's disease of bone. N Engl J Med 1997; 336: 558-66.
3. Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ et al. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. Journal of Bone and Mineral Research 2005; 20: 977-86.
4. Delmas PD. The use of bisphosphonates in the treatment of osteoporosis. Curr Opin Rheumatol 2005; 17: 462-6.
5. Watts NB. Bisphosphonate treatment of osteoporosis. Clin Geriatr Med 2003; 19: 395-414.
6. ADVISORY TASK FORCE ON BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAWS, AMERICAN ASSOCIATION OF ORAL. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2007 Mar; 6: 369-76.
7. González-Moles MA, Bagán-Sebastián JV. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med 2000; 29: 514-8.
8. Ponte-Fernández N, Estefania-Fresco R, Aguirre-Urizar JM. Bisphosphonates and Oral Pathology I. General and preventive aspects. Med Oral Patol Oral Cir Bucal 2006; 11: E396-400.
9. Migliorati CA, Schubert MM, Peterson DE, Seneda LM. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005; 104: 83-93.
10. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonateinduced exposed bone (osteonerosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005; 63: 1567-75.
11. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004; 62: 527-34.
12. Brooks JK, Wilson AJ, Sindler AJ, Ashman SG, Schwartz KG, Nikitakis NG. Osteonecrosis of the jaws associated with use of risedronate: Report of 2 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: 780-6.
13. Levin L, Laviv A, Schwartz-Arad D. Denture-related osteonecrosis of the maxilla associated with oral bisphosphonate treatment. J Am Dent Assoc 2007; 138: 1218-20.
14. Malden NJ, Pai AY. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. Br Dent J 2007; 203: 93-7.
15. AMERICAN DENTAL ASSOCIATION COUNCIL ON SCIENTIFIC AFFAIRSS. Dental management of patients receiving oral bisphosphonate therapy. Expert panel recommendations. J Am Dent Assoc 2006; 137: 1144-50.
16. Bagán JV, Blade J, Cozar JM, Constela M, García Sanz R, Gómez Veiga F et al. Recomendaciones para la prevención, diagnóstico y tratamiento de osteonecrosis de los maxilares (ONM) en pacientes con cáncer tratados con bifosfonatos. Med Oral Patol Oral Cir Bucal 2007; 12: 279-83.
17. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D et al. Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task. Force of the American Society for Bone and Mineral Research (Editorial). J Bone Miner Res 2007; 22: 1479-91.
18. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB. Managing the care of patients with bisphosphonate-associated osteonecrosis. An American Academy of Oral Medicine position paper. J Am Dent Assoc 2005; 136: 1658-68.
19. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonaterelated osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Path Oral Radiol Endod 2006; 102: 433-41.
20. Pires FR, Miranda A, Cardoso ES, Cardosoas, Fregnani ER, Pereira CM et al. Oral avascular bone necrosis associated with chemotherapy and bisphosphonate therapy. Oral Dis 2005; 11: 365-9.